Nevertheless, elevation or stabilization of these inhibitory proteins, including TRAF3, p100, IRF8, and RBP-J, would be a novel strategy to treat a variety of bone diseases with bone loss, including osteoporosis and RA. Here, TRAF3 is linked to rheumatoid arthritis.